← back to database
RiverVest builds and backs life-science companies addressing significant unmet medical needs, with a primary emphasis on biopharma and medical devices. The firm invests from company formation and seed through later venture rounds, leads financings, and assembles investor syndicates.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$275M Fund V
Latest fund vintage
2021
Investing team
Andrew KleiboekerAssociate
Isaac ZikeManaging Director
Jay W. SchmelterCo-Founder & Managing Director
Karen SpilizewskiManaging Director
Nafise MasoumiPrincipal
Niall O'DonnellManaging Director
Pascal KroteePrincipal
Tom MelzerCo-Founder & Managing Director
How to reach them
Notable investments
MacroGenics, Mirum Pharmaceuticals, Xilio Therapeutics, Spruce Biosciences